Literature DB >> 21709741

Mediators of Tyrosine Phosphorylation in Innate Immunity: From Host Defense to Inflammation onto Oncogenesis.

Kamalika Nag1, Anu Chaudhary.   

Abstract

Cells respond to extracellular cues through a variety of receptors on the surface. These signals once transduced across the cell membrane, activate protein tyrosine kinases, which through phosphorylation of substrates on key tyrosine residues, are able to control cellular growth, activation and differentiation pathways. Recent data suggest that protein tyrosine kinases are critical in integrating signals from various cellular receptors, including pathogen detection receptors that mediate the host innate immune response. In this article, we have reviewed the roles of tyrosine kinases of the Tec, FAK, Fps, Fer, Syk, Src and TAM-receptor families in toll-like receptor signaling. The shared roles of these tyrosine phosphorylation mediators in host defense, inflammation, autoimmune disease and oncogenesis provides promising avenues for the use of their inhibitors in multiple disorders.

Entities:  

Year:  2009        PMID: 21709741      PMCID: PMC3123156          DOI: 10.2174/15743620978816750

Source DB:  PubMed          Journal:  Curr Signal Transduct Ther        ISSN: 1574-3624


  64 in total

1.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

2.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

3.  Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells.

Authors:  Anu Chaudhary; Theresa M Fresquez; Michele J Naranjo
Journal:  Immunol Cell Biol       Date:  2007-01-16       Impact factor: 5.126

4.  Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages.

Authors:  Maria J Smolinska; Nicole J Horwood; Theresa H Page; Tim Smallie; Brian M J Foxwell
Journal:  Mol Immunol       Date:  2007-09-17       Impact factor: 4.407

5.  Imatinib for the treatment of rheumatic diseases.

Authors:  Ricardo T Paniagua; William H Robinson
Journal:  Nat Clin Pract Rheumatol       Date:  2007-04

6.  Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury.

Authors:  Mariano Severgnini; Satoe Takahashi; Powen Tu; George Perides; Robert J Homer; Jhung W Jhung; Deepa Bhavsar; Brent H Cochran; Amy R Simon
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

7.  The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-gamma-mediated TNF and iNOS production in murine macrophages.

Authors:  S L Orlicek; J H Hanke; B K English
Journal:  Shock       Date:  1999-11       Impact factor: 3.454

8.  Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain.

Authors:  R Chen; O Kim; M Li; X Xiong; J L Guan; H J Kung; H Chen; Y Shimizu; Y Qiu
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

9.  TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia.

Authors:  Ping Gong; Daniel J Angelini; Shiqi Yang; Guanjun Xia; Alan S Cross; Dean Mann; Douglas D Bannerman; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

10.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  3 in total

1.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

Review 2.  AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review.

Authors:  Chih-Hung Hsu; Yi-Hsiang Huang; Shi-Ming Lin; Chiun Hsu
Journal:  Liver Cancer       Date:  2022-02-10       Impact factor: 12.430

Review 3.  The alpha,alpha-difluorinated phosphonate L-pSer-analogue: an accessible chemical tool for studying kinase-dependent signal transduction.

Authors:  Kaushik Panigrahi; MariJean Eggen; Jun-Ho Maeng; Quanrong Shen; David B Berkowitz
Journal:  Chem Biol       Date:  2009-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.